Rezultaty - Amir Hashemi Meshkini

Making the Public Health and Industrial Objectives Balanced; the Big Challenge of Iran's Food and Drug Organization. od Amir Hashemi-Meshkini

Connect to this object online.

Drug-Eluting Balloon: An Overview of Clinical Evidences on Safety and Effectiveness od Khosro Keshavarz, Amir Hashemi-Meshkini, Pardis Zaboli, Jamal Khedmati, Abbas Kebriaeezadeh

Connect to this object online.

The Effectiveness of Fulvestrant in postmenopausal advanced breast cancer; systematic review of clinical evidence od Amir Hashemi-Meshkini, Khosro Keshavarz, Mehdi Varmaghani, Abbas Kebriaeezadeh, Shekoufeh Nikfar

Connect to this object online.

Evaluation of COVID-19 treatments in Iran in comparison with local therapeutic recommendations: A population-level study on utilization and costs of prescription drugs od Amir Hashemi-Meshkini, Reza Koochak, Shekoufeh Nikfar, Ehsan Rezaei-Darzi, Saeed Yaghoubifard

Connect to this object online.

Determinants and economic burden of HIV/AIDS in Iran: a prospective study od Tahmineh Reshadat-Hajiabad, Alireza Khajavi, Ali Mohammad Hosseinpour, Amin Bojdy, Amir Hashemi-Meshkini, Mehdi Varmaghani

Connect to this object online.

Developing a patient satisfaction questionnaire for services provided in Iranian community pharmacies od Saeed Yaghoubifard, Arash Rashidian, Abbas Kebriaeezadeh, Ali Sheidaei, Mehdi Varmaghani, Amir Hashemi-Meshkini, Hedieh-Sadat Zekri

Connect to this object online.

An overview to pharmaceutical financing in Iran od Mehdi Varmaghani, Amir Hashemi-Meshkini, Akbar Abdollahiasl, Elham Heidari, Hedieh-Sadat Zekri, Saeed Yaghoubifard, Farid Dorkoosh

Connect to this object online.

From generic scheme to brand-generic scheme: Have new policy influenced the efficiency of Iranian pharmaceutical companies? od Amir Hashemi-Meshkini, Mehdi Varmaghani, Mehdi Yousefi, Saeed Yaghoubifard, Hedieh-Sadat Zekri, Shekoufeh Nikfar, Abbas Kebriaeezadeh

Connect to this object online.

Pharmaceutical laws and regulations in Iran: An overview od Pardis Zaboli, Amir Hashemi-Meshkini, Mehdi Varmaghani, Hadi Gholami, Iman Vazirian, Hedieh-Sadat Zekri, Shahriar Eslamitabar, Abbas Kebriaeezadeh

Connect to this object online.

Evaluation of productivity in Iranian pharmaceutical companies: A DEA-based Malmquist approach and panel data analysis od Mehdi Varmaghani, Amir Hashemi Meshkini, Farshad Farzadfar, Mehdi Yousefi, Saeed Yaghoubifard, Vida Varahrami, Ehsan Rezaei Darzi, Majid Anabi, Abbas Kebriaeezadeh, Hedieh-Sadat Zekri

Connect to this object online.